Home › Pancreatic Ductal Carcinoma › California › Orange
Pancreatic Ductal Carcinoma clinical trials in Orange, CA
3 studies for Pancreatic Ductal Carcinoma are looking for participants at sites in and around Orange (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
RecruitingPhase 2
- Site 12, Orange
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- UC IRVINE Health, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecruitingPhase 1/2
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Pancreatic Ductal Carcinoma trials in other cities
- Boston, MA4 studies
- Nashville, TN4 studies
- Scottsdale, AZ3 studies
- Arlington, VA3 studies
- Tampa, FL3 studies
- New York City, NY3 studies
- Houston, TX3 studies
- San Antonio, TX3 studies
- Cincinnati, OH3 studies
Other studies in Orange
- Non-Small Cell Lung Cancer25 studies
- Metastatic Cancer20 studies
- Colorectal Cancer16 studies
- Ovarian Cancer16 studies
- Pancreatic Cancer15 studies
- Melanoma14 studies
- Liver Cancer (Hepatocellular Carcinoma)14 studies
- Breast Cancer14 studies
- Lung Cancer14 studies
- Prostate Cancer14 studies
- Stomach Cancer13 studies
- Cancer (all types)13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.